Edward White
Stock Analyst at HC Wainwright & Co.
(1.48)
# 3,482
Out of 5,180 analysts
338
Total ratings
30.07%
Success rate
-9.42%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Edward White
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics | Reiterates: Buy | $33 | $13.42 | +145.90% | 24 | Apr 16, 2025 | |
| VALN Valneva SE | Reiterates: Buy | $17 | $6.24 | +172.65% | 41 | Apr 15, 2025 | |
| NYXH Nyxoah | Reiterates: Buy | $15 | $2.79 | +437.63% | 15 | Apr 8, 2025 | |
| SABS SAB Biotherapeutics | Reiterates: Buy | $6 | $3.78 | +58.73% | 15 | Apr 1, 2025 | |
| CRIS Curis | Maintains: Buy | $20 → $16 | $0.51 | +3,022.56% | 18 | Mar 31, 2025 | |
| IKT Inhibikase Therapeutics | Reiterates: Neutral | n/a | $1.58 | - | 11 | Mar 28, 2025 | |
| SNSE Sensei Biotherapeutics | Reiterates: Buy | $80 | $25.13 | +218.34% | 6 | Mar 28, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterates: Neutral | n/a | $1.51 | - | 11 | Mar 28, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $20 | $5.45 | +266.97% | 2 | Mar 26, 2025 | |
| BOLT Bolt Biotherapeutics | Reiterates: Neutral | n/a | $4.25 | - | 12 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $4.31 | +271.23% | 7 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $6.20 | +303.23% | 6 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.83 | +861.89% | 25 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $13.93 | - | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $6.11 | - | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $31.51 | +74.55% | 31 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $22.48 | +126.87% | 29 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $6.13 | +14.19% | 20 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $56 | $5.30 | +956.60% | 28 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $101 → $52 | $10.11 | +414.34% | 4 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $0.67 | - | 1 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $31.45 | -4.61% | 5 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $1.13 | +961.95% | 2 | Mar 6, 2018 |
Cullinan Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $33
Current: $13.42
Upside: +145.90%
Valneva SE
Apr 15, 2025
Reiterates: Buy
Price Target: $17
Current: $6.24
Upside: +172.65%
Nyxoah
Apr 8, 2025
Reiterates: Buy
Price Target: $15
Current: $2.79
Upside: +437.63%
SAB Biotherapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $6
Current: $3.78
Upside: +58.73%
Curis
Mar 31, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $0.51
Upside: +3,022.56%
Inhibikase Therapeutics
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.58
Upside: -
Sensei Biotherapeutics
Mar 28, 2025
Reiterates: Buy
Price Target: $80
Current: $25.13
Upside: +218.34%
60 Degrees Pharmaceuticals
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.51
Upside: -
Artiva Biotherapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $20
Current: $5.45
Upside: +266.97%
Bolt Biotherapeutics
Mar 25, 2025
Reiterates: Neutral
Price Target: n/a
Current: $4.25
Upside: -
Mar 25, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $4.31
Upside: +271.23%
Mar 25, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $6.20
Upside: +303.23%
Mar 21, 2025
Reiterates: Buy
Price Target: $8
Current: $0.83
Upside: +861.89%
Mar 20, 2025
Reiterates: Neutral
Price Target: n/a
Current: $13.93
Upside: -
Mar 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $6.11
Upside: -
Mar 4, 2025
Reiterates: Buy
Price Target: $55
Current: $31.51
Upside: +74.55%
Mar 4, 2025
Reiterates: Buy
Price Target: $51
Current: $22.48
Upside: +126.87%
Feb 28, 2025
Reiterates: Buy
Price Target: $7
Current: $6.13
Upside: +14.19%
Feb 26, 2025
Maintains: Buy
Price Target: $7 → $56
Current: $5.30
Upside: +956.60%
Aug 5, 2022
Downgrades: Neutral
Price Target: $101 → $52
Current: $10.11
Upside: +414.34%
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $0.67
Upside: -
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $31.45
Upside: -4.61%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $1.13
Upside: +961.95%